ID   GLYC_HUMAN              Reviewed;         483 AA.
AC   P34896; B4DPM9; D3DXD0; Q96HY0; Q9UMD1; Q9UMD2;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   10-MAY-2017, entry version 181.
DE   RecName: Full=Serine hydroxymethyltransferase, cytosolic;
DE            Short=SHMT;
DE            EC=2.1.2.1 {ECO:0000269|PubMed:24698160, ECO:0000269|PubMed:8505317};
DE   AltName: Full=Glycine hydroxymethyltransferase;
DE   AltName: Full=Serine methylase;
GN   Name=SHMT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=8505317;
RA   Garrow T.A., Brenner A.A., Whitehead M.V., Chen X.-N., Duncan R.G.,
RA   Korenberg J.R., Shane B.;
RT   "Cloning of human cDNAs encoding mitochondrial and cytosolic serine
RT   hydroxymethyltransferases and chromosomal localization.";
RL   J. Biol. Chem. 268:11910-11916(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RA   Xu L., Mangum J.H., Robertson D.L.;
RL   Submitted (JAN-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Mammary gland;
RX   PubMed=9056951; DOI=10.1042/bst025053s;
RA   Chave K.J., Snell K., Sanders P.G.;
RT   "Isolation and characterisation of human genomic sequences encoding
RT   cytosolic serine hydroxymethyltransferase.";
RL   Biochem. Soc. Trans. 25:53-53(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PHE-474.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   PHE-474.
RC   TISSUE=Bone marrow, Lymph, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-271 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE BRISC
RP   COMPLEX, AND INTERACTION WITH FAM175B.
RX   PubMed=24075985; DOI=10.1016/j.celrep.2013.08.025;
RA   Zheng H., Gupta V., Patterson-Fortin J., Bhattacharya S.,
RA   Katlinski K., Wu J., Varghese B., Carbone C.J., Aressy B., Fuchs S.Y.,
RA   Greenberg R.A.;
RT   "A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon
RT   responses.";
RL   Cell Rep. 5:180-193(2013).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME
RP   REGULATION, SUBUNIT, AND COFACTOR.
RX   PubMed=24698160; DOI=10.1111/febs.12803;
RA   Pinthong C., Maenpuen S., Amornwatcharapong W., Yuthavong Y.,
RA   Leartsakulpanich U., Chaiyen P.;
RT   "Distinct biochemical properties of human serine
RT   hydroxymethyltransferase compared with the Plasmodium enzyme:
RT   implications for selective inhibition.";
RL   FEBS J. 281:2570-2583(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   SUBUNIT, AND COFACTOR.
RX   PubMed=25619277; DOI=10.1111/febs.13211;
RA   Giardina G., Brunotti P., Fiascarelli A., Cicalini A., Costa M.G.,
RA   Buckle A.M., di Salvo M.L., Giorgi A., Marani M., Paone A.,
RA   Rinaldo S., Paiardini A., Contestabile R., Cutruzzola F.;
RT   "How pyridoxal 5'-phosphate differentially regulates human cytosolic
RT   and mitochondrial serine hydroxymethyltransferase oligomeric state.";
RL   FEBS J. 282:1225-1241(2015).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 11-480, COFACTOR, AND
RP   SUBUNIT.
RX   PubMed=9753690; DOI=10.1016/S0969-2126(98)00112-9;
RA   Renwick S.B., Snell K., Baumann U.;
RT   "The crystal structure of human cytosolic serine
RT   hydroxymethyltransferase: a target for cancer chemotherapy.";
RL   Structure 6:1105-1116(1998).
CC   -!- FUNCTION: Interconversion of serine and glycine (PubMed:8505317,
CC       PubMed:24698160). {ECO:0000269|PubMed:24698160,
CC       ECO:0000269|PubMed:8505317}.
CC   -!- CATALYTIC ACTIVITY: 5,10-methylenetetrahydrofolate + glycine +
CC       H(2)O = tetrahydrofolate + L-serine. {ECO:0000269|PubMed:24698160,
CC       ECO:0000269|PubMed:8505317}.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:24698160,
CC         ECO:0000269|PubMed:25619277, ECO:0000269|PubMed:9753690};
CC   -!- ENZYME REGULATION: Inhibited by tetrahydrofolate concentrations
CC       above 40 uM. {ECO:0000269|PubMed:24698160}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.18 mM for L-serine {ECO:0000269|PubMed:24698160};
CC         KM=5.2 uM for tetrahydrofolate {ECO:0000269|PubMed:24698160};
CC   -!- PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion.
CC       {ECO:0000305|PubMed:24698160}.
CC   -!- SUBUNIT: Homotetramer (PubMed:24698160, PubMed:25619277,
CC       PubMed:9753690). Identified in complex with FAM175B and the other
CC       subunits of the BRISC complex, at least composed of FAM175B/ABRO1,
CC       BRCC3/BRCC36, BRE/BRCC45 and BABAM1/NBA1 (PubMed:24075985).
CC       {ECO:0000269|PubMed:24075985, ECO:0000269|PubMed:24698160,
CC       ECO:0000269|PubMed:25619277, ECO:0000269|PubMed:9753690}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-715117, EBI-715117;
CC       P45984:MAPK9; NbExp=5; IntAct=EBI-715117, EBI-713568;
CC       P0DMM9:SULT1A3; NbExp=3; IntAct=EBI-715117, EBI-10196922;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P34896-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P34896-2; Sequence=VSP_006095;
CC         Note=Contains a N6-acetyllysine at position 271.
CC         {ECO:0000244|PubMed:19608861};
CC       Name=3;
CC         IsoId=P34896-3; Sequence=VSP_006096;
CC       Name=4;
CC         IsoId=P34896-4; Sequence=VSP_054610;
CC         Note=No experimental confirmation available.;
CC   -!- MISCELLANEOUS: In eukaryotes there are two forms of the enzymes: a
CC       cytosolic one and a mitochondrial one. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the SHMT family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L11931; AAA63257.1; -; mRNA.
DR   EMBL; L23928; AAA36020.1; -; mRNA.
DR   EMBL; L23928; AAA36019.1; -; mRNA.
DR   EMBL; L23928; AAA36018.1; -; mRNA.
DR   EMBL; Y14485; CAB54838.1; -; mRNA.
DR   EMBL; Y14486; CAB54839.1; -; mRNA.
DR   EMBL; Y14487; CAB54840.1; -; mRNA.
DR   EMBL; AK298415; BAG60641.1; -; mRNA.
DR   EMBL; AC127537; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL353997; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471196; EAW55637.1; -; Genomic_DNA.
DR   EMBL; CH471196; EAW55640.1; -; Genomic_DNA.
DR   EMBL; CH471196; EAW55641.1; -; Genomic_DNA.
DR   EMBL; BC007979; AAH07979.1; -; mRNA.
DR   EMBL; BC022874; AAH22874.1; -; mRNA.
DR   EMBL; BC038598; AAH38598.1; -; mRNA.
DR   CCDS; CCDS11196.1; -. [P34896-1]
DR   CCDS; CCDS11197.1; -. [P34896-2]
DR   CCDS; CCDS62112.1; -. [P34896-4]
DR   PIR; A46746; A46746.
DR   RefSeq; NP_001268715.1; NM_001281786.1. [P34896-4]
DR   RefSeq; NP_004160.3; NM_004169.4. [P34896-1]
DR   RefSeq; NP_683718.1; NM_148918.2. [P34896-2]
DR   RefSeq; XP_005256824.1; XM_005256767.3. [P34896-1]
DR   RefSeq; XP_011522294.1; XM_011523992.2. [P34896-3]
DR   RefSeq; XP_016880446.1; XM_017024957.1. [P34896-1]
DR   RefSeq; XP_016880447.1; XM_017024958.1. [P34896-2]
DR   UniGene; Hs.513987; -.
DR   UniGene; Hs.592944; -.
DR   UniGene; Hs.636044; -.
DR   PDB; 1BJ4; X-ray; 2.65 A; A=11-480.
DR   PDBsum; 1BJ4; -.
DR   ProteinModelPortal; P34896; -.
DR   SMR; P34896; -.
DR   BioGrid; 112366; 45.
DR   IntAct; P34896; 11.
DR   STRING; 9606.ENSP00000318868; -.
DR   BindingDB; P34896; -.
DR   ChEMBL; CHEMBL1772927; -.
DR   DrugBank; DB02800; 5-Hydroxymethylene-6-Hydrofolic Acid.
DR   DrugBank; DB00145; Glycine.
DR   DrugBank; DB01055; Mimosine.
DR   DrugBank; DB02824; N-Pyridoxyl-Glycine-5-Monophosphate.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   DrugBank; DB00116; Tetrahydrofolic acid.
DR   DrugBank; DB02067; Triglu-5-Formyl-Tetrahydrofolate.
DR   MoonProt; P34896; -.
DR   iPTMnet; P34896; -.
DR   PhosphoSitePlus; P34896; -.
DR   SwissPalm; P34896; -.
DR   BioMuta; SHMT1; -.
DR   DMDM; 462184; -.
DR   EPD; P34896; -.
DR   MaxQB; P34896; -.
DR   PaxDb; P34896; -.
DR   PeptideAtlas; P34896; -.
DR   PRIDE; P34896; -.
DR   DNASU; 6470; -.
DR   Ensembl; ENST00000316694; ENSP00000318868; ENSG00000176974. [P34896-1]
DR   Ensembl; ENST00000352886; ENSP00000345881; ENSG00000176974. [P34896-4]
DR   Ensembl; ENST00000354098; ENSP00000318805; ENSG00000176974. [P34896-2]
DR   GeneID; 6470; -.
DR   KEGG; hsa:6470; -.
DR   UCSC; uc002gta.5; human. [P34896-1]
DR   CTD; 6470; -.
DR   DisGeNET; 6470; -.
DR   GeneCards; MIR6778; -.
DR   GeneCards; SHMT1; -.
DR   HGNC; HGNC:10850; SHMT1.
DR   HPA; HPA023314; -.
DR   MIM; 182144; gene.
DR   neXtProt; NX_P34896; -.
DR   OpenTargets; ENSG00000176974; -.
DR   PharmGKB; PA35753; -.
DR   eggNOG; KOG2467; Eukaryota.
DR   eggNOG; COG0112; LUCA.
DR   GeneTree; ENSGT00390000002762; -.
DR   HOGENOM; HOG000239405; -.
DR   HOVERGEN; HBG002807; -.
DR   InParanoid; P34896; -.
DR   KO; K00600; -.
DR   OMA; DANNPAV; -.
DR   OrthoDB; EOG091G05AU; -.
DR   PhylomeDB; P34896; -.
DR   TreeFam; TF314667; -.
DR   BioCyc; MetaCyc:HS11114-MONOMER; -.
DR   BRENDA; 2.1.2.1; 2681.
DR   Reactome; R-HSA-196757; Metabolism of folate and pterines.
DR   Reactome; R-HSA-71262; Carnitine synthesis.
DR   UniPathway; UPA00193; -.
DR   ChiTaRS; SHMT1; human.
DR   EvolutionaryTrace; P34896; -.
DR   GenomeRNAi; 6470; -.
DR   PRO; PR:P34896; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000176974; -.
DR   CleanEx; HS_SHMT1; -.
DR   ExpressionAtlas; P34896; baseline and differential.
DR   Genevisible; P34896; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0004372; F:glycine hydroxymethyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008732; F:L-allo-threonine aldolase activity; IEA:Ensembl.
DR   GO; GO:0048027; F:mRNA 5'-UTR binding; IDA:CAFA.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB.
DR   GO; GO:0070905; F:serine binding; IDA:BHF-UCL.
DR   GO; GO:0000900; F:translation repressor activity, nucleic acid binding; IDA:CAFA.
DR   GO; GO:0045329; P:carnitine biosynthetic process; TAS:Reactome.
DR   GO; GO:1904482; P:cellular response to tetrahydrofolate; IDA:BHF-UCL.
DR   GO; GO:0006231; P:dTMP biosynthetic process; IEA:Ensembl.
DR   GO; GO:0046655; P:folic acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0019264; P:glycine biosynthetic process from serine; IEA:Ensembl.
DR   GO; GO:0006544; P:glycine metabolic process; IDA:UniProtKB.
DR   GO; GO:0006565; P:L-serine catabolic process; IDA:UniProtKB.
DR   GO; GO:0006563; P:L-serine metabolic process; IDA:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; IDA:CAFA.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0051262; P:protein tetramerization; IDA:UniProtKB.
DR   GO; GO:0009113; P:purine nucleobase biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0035999; P:tetrahydrofolate interconversion; IDA:BHF-UCL.
DR   GO; GO:0046653; P:tetrahydrofolate metabolic process; IDA:UniProtKB.
DR   CDD; cd00378; SHMT; 1.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   HAMAP; MF_00051; SHMT; 1.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major_sub1.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_sub2.
DR   InterPro; IPR001085; Ser_HO-MeTrfase.
DR   InterPro; IPR019798; Ser_HO-MeTrfase_PLP_BS.
DR   PANTHER; PTHR11680; PTHR11680; 1.
DR   Pfam; PF00464; SHMT; 1.
DR   PIRSF; PIRSF000412; SHMT; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   PROSITE; PS00096; SHMT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; One-carbon metabolism; Polymorphism; Pyridoxal phosphate;
KW   Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P07511}.
FT   CHAIN         2    483       Serine hydroxymethyltransferase,
FT                                cytosolic.
FT                                /FTId=PRO_0000113504.
FT   MOD_RES     257    257       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000244|PDB:1BJ4,
FT                                ECO:0000269|PubMed:9753690}.
FT   VAR_SEQ       1    138       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054610.
FT   VAR_SEQ     273    352       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_006096.
FT   VAR_SEQ     274    312       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_006095.
FT   VARIANT     340    340       E -> Q (in dbSNP:rs7215148).
FT                                /FTId=VAR_059795.
FT   VARIANT     474    474       L -> F (in dbSNP:rs1979277).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_022010.
FT   HELIX        13     21       {ECO:0000244|PDB:1BJ4}.
FT   HELIX        26     29       {ECO:0000244|PDB:1BJ4}.
FT   HELIX        31     46       {ECO:0000244|PDB:1BJ4}.
FT   STRAND       47     49       {ECO:0000244|PDB:1BJ4}.
FT   HELIX        59     65       {ECO:0000244|PDB:1BJ4}.
FT   HELIX        68     70       {ECO:0000244|PDB:1BJ4}.
FT   STRAND       80     84       {ECO:0000244|PDB:1BJ4}.
FT   HELIX        87    103       {ECO:0000244|PDB:1BJ4}.
FT   TURN        108    110       {ECO:0000244|PDB:1BJ4}.
FT   STRAND      111    114       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       120    131       {ECO:0000244|PDB:1BJ4}.
FT   STRAND      137    141       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       143    145       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       149    151       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       162    166       {ECO:0000244|PDB:1BJ4}.
FT   STRAND      167    172       {ECO:0000244|PDB:1BJ4}.
FT   TURN        176    178       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       183    193       {ECO:0000244|PDB:1BJ4}.
FT   STRAND      196    200       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       211    220       {ECO:0000244|PDB:1BJ4}.
FT   STRAND      224    228       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       230    232       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       233    237       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       244    246       {ECO:0000244|PDB:1BJ4}.
FT   STRAND      249    256       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       257    259       {ECO:0000244|PDB:1BJ4}.
FT   STRAND      265    270       {ECO:0000244|PDB:1BJ4}.
FT   STRAND      272    276       {ECO:0000244|PDB:1BJ4}.
FT   TURN        278    280       {ECO:0000244|PDB:1BJ4}.
FT   STRAND      283    285       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       288    296       {ECO:0000244|PDB:1BJ4}.
FT   TURN        297    300       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       306    318       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       322    344       {ECO:0000244|PDB:1BJ4}.
FT   STRAND      355    362       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       363    366       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       370    379       {ECO:0000244|PDB:1BJ4}.
FT   STRAND      385    387       {ECO:0000244|PDB:1BJ4}.
FT   STRAND      400    404       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       406    410       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       415    438       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       445    452       {ECO:0000244|PDB:1BJ4}.
FT   STRAND      453    455       {ECO:0000244|PDB:1BJ4}.
FT   HELIX       458    472       {ECO:0000244|PDB:1BJ4}.
SQ   SEQUENCE   483 AA;  53083 MW;  6CDD6CA06D017C19 CRC64;
     MTMPVNGAHK DADLWSSHDK MLAQPLKDSD VEVYNIIKKE SNRQRVGLEL IASENFASRA
     VLEALGSCLN NKYSEGYPGQ RYYGGTEFID ELETLCQKRA LQAYKLDPQC WGVNVQPYSG
     SPANFAVYTA LVEPHGRIMG LDLPDGGHLT HGFMTDKKKI SATSIFFESM PYKVNPDTGY
     INYDQLEENA RLFHPKLIIA GTSCYSRNLE YARLRKIADE NGAYLMADMA HISGLVAAGV
     VPSPFEHCHV VTTTTHKTLR GCRAGMIFYR KGVKSVDPKT GKEILYNLES LINSAVFPGL
     QGGPHNHAIA GVAVALKQAM TLEFKVYQHQ VVANCRALSE ALTELGYKIV TGGSDNHLIL
     VDLRSKGTDG GRAEKVLEAC SIACNKNTCP GDRSALRPSG LRLGTPALTS RGLLEKDFQK
     VAHFIHRGIE LTLQIQSDTG VRATLKEFKE RLAGDKYQAA VQALREEVES FASLFPLPGL
     PDF
//
